Prosight Management, LP - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 42 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Prosight Management, LP ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$4,097,000
-23.4%
341,457
-22.1%
2.28%
-41.7%
Q2 2018$5,349,000
+2.3%
438,422
-17.4%
3.92%
+19.6%
Q1 2018$5,229,000
-44.8%
530,848
-21.8%
3.28%
-52.9%
Q4 2017$9,469,000678,7936.96%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders